

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.31273655 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.31273655 |
| 3 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.90732249 |
| 4 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.58346911 |
| 5 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 6.30166550 |
| 6 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.82938917 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.67811409 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.31461894 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.31461894 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.31461894 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.31461894 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.31461894 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 5.31461894 |
| 14 | detection of other organism (GO:0098543) | 5.30024079 |
| 15 | detection of bacterium (GO:0016045) | 5.26693735 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83419102 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.80691752 |
| 18 | leukocyte aggregation (GO:0070486) | 4.59325288 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.54769996 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.53846103 |
| 21 | response to interleukin-15 (GO:0070672) | 4.40474897 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.36951126 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.30391701 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17784132 |
| 25 | response to peptidoglycan (GO:0032494) | 4.10926224 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.10318193 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.07373346 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.05783163 |
| 29 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.05325806 |
| 30 | * type I interferon signaling pathway (GO:0060337) | 3.95276376 |
| 31 | * cellular response to type I interferon (GO:0071357) | 3.95276376 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.94141334 |
| 33 | * response to type I interferon (GO:0034340) | 3.92603471 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91053316 |
| 35 | respiratory burst (GO:0045730) | 3.89790413 |
| 36 | neutrophil activation (GO:0042119) | 3.87997777 |
| 37 | cellular extravasation (GO:0045123) | 3.83254140 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.82946112 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76622067 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.73533556 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.67282204 |
| 42 | regulation of tolerance induction (GO:0002643) | 3.64595468 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.62588238 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.60830403 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60342737 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59089851 |
| 47 | response to host immune response (GO:0052572) | 3.59089851 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.57646626 |
| 49 | granulocyte activation (GO:0036230) | 3.55702022 |
| 50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.52712826 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.52712826 |
| 52 | negative T cell selection (GO:0043383) | 3.48862447 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 3.43994494 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.42875324 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42411596 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.41841475 |
| 57 | positive thymic T cell selection (GO:0045059) | 3.40951324 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.39044425 |
| 59 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37979693 |
| 60 | response to host (GO:0075136) | 3.35604773 |
| 61 | response to host defenses (GO:0052200) | 3.35604773 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35604773 |
| 63 | microglial cell activation (GO:0001774) | 3.26795053 |
| 64 | negative regulation of innate immune response (GO:0045824) | 3.26563867 |
| 65 | germinal center formation (GO:0002467) | 3.25609950 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24054329 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.23757287 |
| 68 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.22826200 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21038026 |
| 70 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20149528 |
| 71 | B cell mediated immunity (GO:0019724) | 3.19036921 |
| 72 | defense response to protozoan (GO:0042832) | 3.17948861 |
| 73 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17934803 |
| 74 | tolerance induction (GO:0002507) | 3.16800288 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15738850 |
| 76 | macrophage activation (GO:0042116) | 3.15393044 |
| 77 | T cell migration (GO:0072678) | 3.12922615 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12167449 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.10758979 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10292605 |
| 81 | regulation of leukocyte degranulation (GO:0043300) | 3.09476020 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08480850 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.08144876 |
| 84 | neutrophil mediated immunity (GO:0002446) | 3.08080146 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07570351 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 3.04617435 |
| 87 | T cell selection (GO:0045058) | 3.02854302 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 3.02222656 |
| 89 | thymic T cell selection (GO:0045061) | 2.99616536 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99128147 |
| 91 | leukocyte degranulation (GO:0043299) | 2.98860204 |
| 92 | negative regulation of type 2 immune response (GO:0002829) | 2.98158717 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97087566 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 2.95783590 |
| 95 | positive regulation of tolerance induction (GO:0002645) | 2.95433938 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95362160 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95362160 |
| 98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.94942699 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.93637773 |
| 100 | positive T cell selection (GO:0043368) | 2.89380438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.27601264 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59405055 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.77628404 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.68351715 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39981528 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25180445 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.09926148 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92657165 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87915019 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81704124 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69893927 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61513082 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56633564 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54372566 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.51513480 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46960473 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46544299 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43545341 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.43100582 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39466087 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39245000 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34163703 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.30955139 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.29734288 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.26950213 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24975916 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24593954 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22169742 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.14259550 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08723615 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06325433 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05334665 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04443993 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 2.01633276 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93369497 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91936222 |
| 37 | * MAF_26560356_Chip-Seq_TH2_Human | 1.89782734 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86364396 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85689797 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85415788 |
| 41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81776113 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80149068 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80140390 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69170372 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68093088 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61930535 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57002669 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54368528 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53129106 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49161241 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45845003 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44696728 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43658648 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42979247 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42159853 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40642591 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40479158 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33820094 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33786825 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33407366 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31446837 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30508486 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28255794 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26547611 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26526112 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22940730 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21773783 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21563493 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19106156 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18743792 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18634300 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17840044 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17163596 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16952919 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13944856 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13600423 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13343306 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12764753 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12679956 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09583320 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08148685 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07605988 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07584218 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06883996 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06288989 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01757164 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01748375 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99093209 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98369583 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96066240 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96008751 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94125614 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93842254 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91700590 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.87380262 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87356919 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86027446 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86003145 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83208576 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81925436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.72160558 |
| 2 | MP0003436_decreased_susceptibility_to | 4.40276452 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.80324017 |
| 4 | MP0003303_peritoneal_inflammation | 3.67479364 |
| 5 | MP0005671_abnormal_response_to | 3.22796421 |
| 6 | MP0002419_abnormal_innate_immunity | 3.04895160 |
| 7 | MP0005387_immune_system_phenotype | 3.02327522 |
| 8 | MP0001790_abnormal_immune_system | 3.02327522 |
| 9 | MP0001800_abnormal_humoral_immune | 2.99618672 |
| 10 | MP0000685_abnormal_immune_system | 2.97697504 |
| 11 | MP0005025_abnormal_response_to | 2.96145712 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.91729401 |
| 13 | MP0009785_altered_susceptibility_to | 2.88839326 |
| 14 | MP0006082_CNS_inflammation | 2.76581584 |
| 15 | MP0002723_abnormal_immune_serum | 2.64035758 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.61580142 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.58624808 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.57786827 |
| 19 | MP0001819_abnormal_immune_cell | 2.55275050 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.53891375 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.30434857 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.29835140 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.22865847 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.09943373 |
| 25 | MP0002405_respiratory_system_inflammati | 2.07919965 |
| 26 | MP0002398_abnormal_bone_marrow | 1.95147262 |
| 27 | MP0000716_abnormal_immune_system | 1.93023019 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.90758371 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.90181771 |
| 30 | MP0004947_skin_inflammation | 1.82150437 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.81093208 |
| 32 | MP0003866_abnormal_defecation | 1.80286173 |
| 33 | MP0008260_abnormal_autophagy | 1.78612955 |
| 34 | MP0002132_abnormal_respiratory_system | 1.76845385 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.65450797 |
| 36 | MP0002722_abnormal_immune_system | 1.59117285 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.58905091 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.58576851 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.57213790 |
| 40 | MP0005451_abnormal_body_composition | 1.53847954 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.53389280 |
| 42 | MP0002429_abnormal_blood_cell | 1.52130062 |
| 43 | MP0008469_abnormal_protein_level | 1.50575360 |
| 44 | MP0009278_abnormal_bone_marrow | 1.50141817 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.49234371 |
| 46 | MP0003828_pulmonary_edema | 1.45619610 |
| 47 | MP0000858_altered_metastatic_potential | 1.44858745 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.40841508 |
| 49 | MP0004510_myositis | 1.37539736 |
| 50 | MP0005310_abnormal_salivary_gland | 1.36202987 |
| 51 | MP0009764_decreased_sensitivity_to | 1.35793139 |
| 52 | MP0004381_abnormal_hair_follicle | 1.31912366 |
| 53 | MP0001851_eye_inflammation | 1.31462485 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.25967565 |
| 55 | MP0001873_stomach_inflammation | 1.25525269 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.24532581 |
| 57 | MP0004883_abnormal_blood_vessel | 1.20448684 |
| 58 | MP0003075_altered_response_to | 1.20258968 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.11699775 |
| 60 | MP0005166_decreased_susceptibility_to | 1.09824985 |
| 61 | MP0003690_abnormal_glial_cell | 1.04173749 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.02494600 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.02494600 |
| 64 | MP0000490_abnormal_crypts_of | 1.01310644 |
| 65 | MP0005164_abnormal_response_to | 1.00876193 |
| 66 | MP0002933_joint_inflammation | 0.96815859 |
| 67 | MP0003448_altered_tumor_morphology | 0.96225805 |
| 68 | MP0005390_skeleton_phenotype | 0.95625533 |
| 69 | MP0001663_abnormal_digestive_system | 0.93299709 |
| 70 | MP0000343_altered_response_to | 0.89414633 |
| 71 | MP0009763_increased_sensitivity_to | 0.87009921 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.85657159 |
| 73 | MP0001853_heart_inflammation | 0.85047199 |
| 74 | MP0009840_abnormal_foam_cell | 0.84560224 |
| 75 | MP0000604_amyloidosis | 0.82875648 |
| 76 | MP0004858_abnormal_nervous_system | 0.78497745 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.77473585 |
| 78 | MP0008004_abnormal_stomach_pH | 0.76649780 |
| 79 | MP0003045_fibrosis | 0.74627678 |
| 80 | MP0003795_abnormal_bone_structure | 0.69399224 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.68431804 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.67276123 |
| 83 | MP0002006_tumorigenesis | 0.66503271 |
| 84 | MP0008874_decreased_physiological_sensi | 0.66373714 |
| 85 | MP0000249_abnormal_blood_vessel | 0.65652153 |
| 86 | MP0003091_abnormal_cell_migration | 0.65649126 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.62286410 |
| 88 | MP0001958_emphysema | 0.56573221 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.55884516 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.54329606 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.52379923 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.51473240 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 0.49405560 |
| 94 | MP0000609_abnormal_liver_physiology | 0.48317385 |
| 95 | MP0002133_abnormal_respiratory_system | 0.47234978 |
| 96 | MP0005388_respiratory_system_phenotype | 0.47234978 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.47147232 |
| 98 | MP0004130_abnormal_muscle_cell | 0.46985436 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.46982523 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.46308847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.99105626 |
| 2 | Myositis (HP:0100614) | 5.93072930 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.73950182 |
| 4 | Orchitis (HP:0100796) | 5.56482911 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.56348973 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.38651787 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.13226232 |
| 8 | Optic neuritis (HP:0100653) | 5.13226232 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.80198331 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.79676183 |
| 11 | Stomatitis (HP:0010280) | 4.56109837 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.42813194 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.18402877 |
| 14 | Meningitis (HP:0001287) | 4.15613545 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.06820407 |
| 16 | Obstructive lung disease (HP:0006536) | 4.05996219 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05996219 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.02942439 |
| 19 | Increased IgE level (HP:0003212) | 3.87468970 |
| 20 | Encephalitis (HP:0002383) | 3.76921109 |
| 21 | Recurrent skin infections (HP:0001581) | 3.71313991 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.70915811 |
| 23 | Vasculitis (HP:0002633) | 3.64270028 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.61750199 |
| 25 | Gingivitis (HP:0000230) | 3.48122583 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.41536178 |
| 27 | Cellulitis (HP:0100658) | 3.37471782 |
| 28 | Urticaria (HP:0001025) | 3.36986305 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34894142 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34894142 |
| 31 | Chest pain (HP:0100749) | 3.26587366 |
| 32 | T lymphocytopenia (HP:0005403) | 3.14306286 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.13237182 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.06633118 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.02185543 |
| 36 | Hemoptysis (HP:0002105) | 3.00580033 |
| 37 | Pustule (HP:0200039) | 2.93915835 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.92108028 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.87075924 |
| 40 | Recurrent viral infections (HP:0004429) | 2.86490905 |
| 41 | Episodic fever (HP:0001954) | 2.81545288 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.79809582 |
| 43 | Increased IgM level (HP:0003496) | 2.78070829 |
| 44 | Abnormality of T cells (HP:0002843) | 2.72697252 |
| 45 | Leukocytosis (HP:0001974) | 2.71513387 |
| 46 | Pulmonary embolism (HP:0002204) | 2.69372858 |
| 47 | Arterial thrombosis (HP:0004420) | 2.68031734 |
| 48 | Lymphopenia (HP:0001888) | 2.63919059 |
| 49 | Peritonitis (HP:0002586) | 2.63918490 |
| 50 | Hypochromic anemia (HP:0001931) | 2.63173287 |
| 51 | Anorexia (HP:0002039) | 2.62095943 |
| 52 | Gingival bleeding (HP:0000225) | 2.60535400 |
| 53 | Petechiae (HP:0000967) | 2.59386783 |
| 54 | Epistaxis (HP:0000421) | 2.58056671 |
| 55 | Granulocytopenia (HP:0001913) | 2.54348752 |
| 56 | Amyloidosis (HP:0011034) | 2.52287036 |
| 57 | Osteomyelitis (HP:0002754) | 2.52278114 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49082673 |
| 59 | Colitis (HP:0002583) | 2.47534120 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.46514614 |
| 61 | Sepsis (HP:0100806) | 2.42104434 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.40726964 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.38762792 |
| 64 | Nasal polyposis (HP:0100582) | 2.37445253 |
| 65 | Chronic otitis media (HP:0000389) | 2.37231061 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.35914787 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.32906081 |
| 68 | Purpura (HP:0000979) | 2.32332230 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.31527771 |
| 70 | Gangrene (HP:0100758) | 2.30848739 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.24481947 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.21267769 |
| 73 | IgM deficiency (HP:0002850) | 2.20942421 |
| 74 | Loss of speech (HP:0002371) | 2.16999860 |
| 75 | Glomerulopathy (HP:0100820) | 2.16479556 |
| 76 | Skin ulcer (HP:0200042) | 2.15123024 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.13950258 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.12912316 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.12406966 |
| 80 | Eosinophilia (HP:0001880) | 2.07944710 |
| 81 | Acute hepatic failure (HP:0006554) | 2.07609815 |
| 82 | Acne (HP:0001061) | 2.07425121 |
| 83 | Increased serum ferritin (HP:0003281) | 2.05766015 |
| 84 | Recurrent sinusitis (HP:0011108) | 2.02190299 |
| 85 | Abnormality of the endocardium (HP:0004306) | 2.00452451 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00082549 |
| 87 | Recurrent pneumonia (HP:0006532) | 1.99137361 |
| 88 | Restrictive lung disease (HP:0002091) | 1.98761497 |
| 89 | Malnutrition (HP:0004395) | 1.98624678 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 1.98112411 |
| 91 | Microcytic anemia (HP:0001935) | 1.97419167 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93991568 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93991568 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93991568 |
| 95 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93595019 |
| 96 | Abnormality of the pericardium (HP:0001697) | 1.93456584 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 1.91994021 |
| 98 | Papilloma (HP:0012740) | 1.90541117 |
| 99 | Verrucae (HP:0200043) | 1.90541117 |
| 100 | Skin rash (HP:0000988) | 1.90373992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.46341081 |
| 2 | MAP4K1 | 4.12582198 |
| 3 | ERN1 | 3.48492696 |
| 4 | TYK2 | 2.98038858 |
| 5 | IRAK4 | 2.88698026 |
| 6 | BLK | 2.74847496 |
| 7 | CSK | 2.64951378 |
| 8 | MAP2K3 | 2.59067850 |
| 9 | PRPF4B | 2.57089663 |
| 10 | FES | 2.42706314 |
| 11 | EPHB1 | 2.33222204 |
| 12 | TNK2 | 2.31364509 |
| 13 | ZAP70 | 2.18639356 |
| 14 | GRK6 | 2.17163461 |
| 15 | JAK3 | 1.87944985 |
| 16 | TXK | 1.84987943 |
| 17 | MAP3K3 | 1.82680998 |
| 18 | BTK | 1.82432702 |
| 19 | TAOK1 | 1.78566723 |
| 20 | HCK | 1.70223930 |
| 21 | MAP3K11 | 1.67713968 |
| 22 | TBK1 | 1.59901240 |
| 23 | MAP3K14 | 1.58531420 |
| 24 | IKBKE | 1.57851234 |
| 25 | SYK | 1.56379479 |
| 26 | SIK3 | 1.54758022 |
| 27 | MAP3K13 | 1.52821191 |
| 28 | FGR | 1.50039784 |
| 29 | TRIB3 | 1.49666701 |
| 30 | JAK1 | 1.48641061 |
| 31 | JAK2 | 1.33875413 |
| 32 | LYN | 1.32340100 |
| 33 | SMG1 | 1.26343416 |
| 34 | LCK | 1.25552896 |
| 35 | MAP3K1 | 1.23922381 |
| 36 | CSF1R | 1.16135742 |
| 37 | KSR2 | 1.15392682 |
| 38 | TESK2 | 1.14811228 |
| 39 | ITK | 1.12877503 |
| 40 | KIT | 1.12222323 |
| 41 | FGFR4 | 1.11301055 |
| 42 | PTK6 | 1.11262456 |
| 43 | PRKD2 | 1.05337840 |
| 44 | TAOK3 | 1.02355464 |
| 45 | MARK3 | 1.01879319 |
| 46 | YES1 | 1.01178086 |
| 47 | SIK2 | 1.00331346 |
| 48 | MARK2 | 0.98082496 |
| 49 | STK10 | 0.96611727 |
| 50 | TAOK2 | 0.96171270 |
| 51 | PDK1 | 0.89087320 |
| 52 | SIK1 | 0.87765685 |
| 53 | IKBKB | 0.84551637 |
| 54 | CDC42BPA | 0.82009275 |
| 55 | MATK | 0.81009763 |
| 56 | PDPK1 | 0.78293997 |
| 57 | IRAK1 | 0.75704092 |
| 58 | LRRK2 | 0.75227105 |
| 59 | TGFBR2 | 0.72976748 |
| 60 | TEC | 0.70801988 |
| 61 | FGFR3 | 0.69817057 |
| 62 | CDK19 | 0.69507517 |
| 63 | FYN | 0.69243405 |
| 64 | MAP3K7 | 0.67354096 |
| 65 | EPHA3 | 0.66208197 |
| 66 | HIPK2 | 0.65749085 |
| 67 | MAPK12 | 0.65356162 |
| 68 | BMPR2 | 0.61913285 |
| 69 | PRKCQ | 0.61603048 |
| 70 | DYRK1B | 0.59707642 |
| 71 | IRAK2 | 0.58891843 |
| 72 | MAPK7 | 0.57652458 |
| 73 | MAP3K6 | 0.55063807 |
| 74 | NLK | 0.52119168 |
| 75 | RIPK1 | 0.50172648 |
| 76 | STK38 | 0.49066526 |
| 77 | PTK2B | 0.46947092 |
| 78 | CAMKK1 | 0.46647221 |
| 79 | STK11 | 0.45578581 |
| 80 | PRKG2 | 0.45446279 |
| 81 | RET | 0.45252204 |
| 82 | MAP3K2 | 0.44362244 |
| 83 | RPS6KC1 | 0.42684217 |
| 84 | RPS6KL1 | 0.42684217 |
| 85 | PIM1 | 0.42517502 |
| 86 | MAP3K5 | 0.40318024 |
| 87 | MAP2K6 | 0.39948592 |
| 88 | MAPKAPK2 | 0.39436052 |
| 89 | GRK7 | 0.36790084 |
| 90 | PRKCH | 0.36331771 |
| 91 | PKN2 | 0.35634231 |
| 92 | RPS6KA6 | 0.33413301 |
| 93 | SGK3 | 0.33123626 |
| 94 | KDR | 0.32645810 |
| 95 | MAP3K10 | 0.32590965 |
| 96 | MAPK11 | 0.32228007 |
| 97 | MAP3K8 | 0.31765810 |
| 98 | RAF1 | 0.28965657 |
| 99 | IRAK3 | 0.28677369 |
| 100 | PRKCD | 0.28658817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92243692 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.89868855 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87746420 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.73524178 |
| 5 | * Allograft rejection_Homo sapiens_hsa05330 | 2.73198194 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.56324133 |
| 7 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55756807 |
| 8 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.37629572 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26230769 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.03755237 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.03226889 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98831615 |
| 13 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98549196 |
| 14 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95597219 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92822656 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.84336215 |
| 17 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.80777477 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73530055 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73110384 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67648159 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67264836 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64892945 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.62248877 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60231588 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59036980 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58301312 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.55302389 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55239303 |
| 29 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.45696057 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45668812 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.43984248 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41991017 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41300316 |
| 34 | * Phagosome_Homo sapiens_hsa04145 | 1.34992579 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34355083 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33558203 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30266514 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27944064 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.22180357 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.17543617 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12206996 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.10466353 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09067674 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.06292912 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.02289013 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01591607 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.00614747 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99158379 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.96972763 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94617045 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.93990531 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93148340 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90821516 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89622795 |
| 55 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88343030 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87114348 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87101215 |
| 58 | * Endocytosis_Homo sapiens_hsa04144 | 0.80500274 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.77459746 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77381947 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73876676 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72529227 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72365064 |
| 64 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70540490 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70215141 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68944753 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67147680 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66879773 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66452489 |
| 70 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66176029 |
| 71 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.59554154 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58152181 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57453264 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56110778 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56026583 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.55957355 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55594993 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54015122 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53385291 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50755570 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.49717824 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49517995 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49217307 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44477551 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44429016 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43851622 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43139299 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42211511 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41843446 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40761068 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39258184 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37673971 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37438064 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33810987 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33801059 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32259362 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31327794 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30686596 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30127815 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.29077863 |

